Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer

Gastroenterology

Volumn 127, Issue 2, 2004, Pages 457-469

  Leung, Suet Yi ^a   Yuen, Siu Tsan ^a   Chu, Kent Man ^a   Mathy, Jonathan A ^b   Li, Rui ^b   Chan, Annie S Y ^a   Law, Simon ^a   Wong, John ^a   Chen, Xin ^c   So, Samuel ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACP; CCL; chemokine (C C motif) ligand; CI; confidence interval; hazard ratio; HR; IHC; immunohistochemistry; matrix metalloproteinase; MMP; reverse transcription polymerase chain reaction; RT PCR; SSC; standard saline citrate; tartrate resistant acid phosphatase

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CHEMOKINE LIGAND 18; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STOMACH CANCER; SURVIVAL RATE;

EID: 4143110195     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.05.031     Document Type: Article

References (38)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 80:1999;827-841
2. Pisani P., Parkin D.M., Bray F., Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 83:1999;18-29
3. Neugut A.I., Hayek M., Howe G. Epidemiology of gastric cancer. Semin Oncol. 23:1996;281-291
4. Leung S.Y., Chen X., Chu K.M., Yuen S.T., Mathy J., Ji J., Chan A.S., Li R., Law S., Troyanskaya O.G., Tu I.P., Wong J., So S., Botstein D., Brown P.O. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A. 99:2002;16203-16208
5. Chen X., Leung S.Y., Yuen S.T., Chu K.M., Ji J., Li R., Chan A.S., Law S., Troyanskaya O.G., Wong J., So S., Botstein D., Brown P.O. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell. 14:2003;3208-3215
6. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med. 338:1998;436-445
7. Zlotnik A., Yoshie O. Chemokines a new classification system and their role in immunity. Immunity. 12:2000;121-127
8. Homey B., Muller A., Zlotnik A. Chemokines agents for the immunotherapy of cancer? Nat Rev Immunol. 2:2002;175-184
9. Adema G.J., Hartgers F., Verstraten R., de Vries E., Marland G., Menon S., Foster J., Xu Y., Nooyen P., McClanahan T., Bacon K.B., Figdor C.G. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature. 387:1997;713-717
10. Hieshima K., Imai T., Baba M., Shoudai K., Ishizuka K., Nakagawa T., Tsuruta J., Takeya M., Sakaki Y., Takatsuki K., Miura R., Opdenakker G., Van Damme J., Yoshie O., Nomiyama H. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol. 159:1997;1140-1149
11. Kodelja V., Muller C., Politz O., Hakij N., Orfanos C.E., Goerdt S. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol. 160:1998;1411-1418
12. Guan P., Burghes A.H., Cunningham A., Lira P., Brissette W.H., Neote K., McColl S.R. Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/SCYA18. Genomics. 56:1999;296-302
13. Tasaki Y., Fukuda S., Iio M., Miura R., Imai T., Sugano S., Yoshie O., Hughes A.L., Nomiyama H. Chemokine PARC gene (SCYA18) generated by fusion of two MIP-1alpha/LD78alpha-like genes. Genomics. 55:1999;353-357
14. Lindhout E., Vissers J.L., Hartgers F.C., Huijbens R.J., Scharenborg N.M., Figdor C.G., Adema G.J. The dendritic cell-specific CC-chemokine DC-CK1 is expressed by germinal center dendritic cells and attracts CD38-negative mantle zone B lymphocytes. J Immunol. 166:2001;3284-3289
15. Schutyser E., Struyf S., Wuyts A., Put W., Geboes K., Grillet B., Opdenakker G., Van Damme J. Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis. Eur J Immunol. 31:2001;3755-3762
16. Kusano F., Tanaka Y., Marumo F., Sato C. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab Invest. 80:2000;415-422
17. Pardo A., Smith K.M., Abrams J., Coffman R., Bustos M., McClanahan T.K., Grein J., Murphy E.E., Zlotnik A., Selman M. CCL18/DC-CK-1/PARC up-regulation in hypersensitivity pneumonitis. J Leukoc Biol. 70:2001;610-616
18. Reape T.J., Rayner K., Manning C.D., Gee A.N., Barnette M.S., Burnand K.G., Groot P.H. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am J Pathol. 154:1999;365-374
19. Schutyser E., Struyf S., Proost P., Opdenakker G., Laureys G., Verhasselt B., Peperstraete L., Van de Putte I., Saccani A., Allavena P., Mantovani A., Van Damme J. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J Biol Chem. 277:2002;24584-24593
20. Zeidler R., Reisbach G., Wollenberg B., Lang S., Chaubal S., Schmitt B., Lindhofer H. Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing. J Immunol. 163:1999;1246-1252
21. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 25:2000;169-193
22. Huang X.R., Chun Hui C.W., Chen Y.X., Wong B.C., Fung P.C., Metz C., Cho C.H., Hui W.M., Bucala R., Lam S.K., Lan H.Y., Chun B., Wong Y. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology. 121:2001;619-630
23. St Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., Kinzler K.W. Genes expressed in human tumor endothelium. Science. 289:2000;1197-1202
24. Iacobuzio-Donahue C.A., Argani P., Hempen P.M., Jones J., Kern S.E. The desmoplastic response to infiltrating breast carcinoma gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res. 62:2002;5351-5357
25. Shapiro S.D., Kobayashi D.K., Ley T.J. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem. 268:1993;23824-23829
26. Lord D.K., Cross N.C., Bevilacqua M.A., Rider S.H., Gorman P.A., Groves A.V., Moss D.W., Sheer D., Cox T.M. Type 5 acid phosphatase. Sequence, expression and chromosomal localization of a differentiation-associated protein of the human macrophage. Eur J Biochem. 189:1990;287-293
27. Beer D.G., Kardia S.L., Huang C.C., Giordano T.J., Levin A.M., Misek D.E., Lin L., Chen G., Gharib T.G., Thomas D.G., Lizyness M.L., Kuick R., Hayasaka S., Taylor J.M., Iannettoni M.D., Orringer M.B., Hanash S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 8:2002;816-824
28. Dhanasekaran S.M., Barrette T.R., Ghosh D., Shah R., Varambally S., Kurachi K., Pienta K.J., Rubin M.A., Chinnaiyan A.M. Delineation of prognostic biomarkers in prostate cancer. Nature. 412:2001;822-826
29. Pomeroy S.L., Tamayo P., Gaasenbeek M., Sturla L.M., Angelo M., McLaughlin M.E., Kim J.Y., Goumnerova L.C., Black P.M., Lau C., Allen J.C., Zagzag D., Olson J.M., Curran T., Wetmore C., Biegel J.A., Poggio T., Mukherjee S., Rifkin R., Califano A., Stolovitzky G., Louis D.N., Mesirov J.P., Lander E.S., Golub T.R. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 415:2002;436-442
30. Singh D., Febbo P.G., Ross K., Jackson D.G., Manola J., Ladd C., Tamayo P., Renshaw A.A., D'Amico A.V., Richie J.P., Lander E.S., Loda M., Kantoff P.W., Golub T.R., Sellers W.R. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 1:2002;203-209
31. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:2002;530-536
32. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., Parrish M., Atsma D., Witteveen A., Glas A., Delahaye L., van der Velde T., Bartelink H., Rodenhuis S., Rutgers E.T., Friend S.H., Bernards R. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 347:2002;1999-2009
33. Rosenwald A., Wright G., Chan W.C., Connors J.M., Campo E., Fisher R.I., Gascoyne R.D., Muller-Hermelink H.K., Smeland E.B., Giltnane J.M., Hurt E.M., Zhao H., Averett L., Yang L., Wilson W.H., Jaffe E.S., Simon R., Klausner R.D., Powell J., Duffey P.L., Longo D.L., Greiner T.C., Weisenburger D.D., Sanger W.G., Dave B.J., Lynch J.C., Vose J., Armitage J.O., Montserrat E., Lopez-Guillermo A., Grogan T.M., Miller T.P., LeBlanc M., Ott G., Kvaloy S., Delabie J., Holte H., Krajci P., Stokke T., Staudt L.M. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 346:2002;1937-1947
34. Ohno S., Inagawa H., Dhar D.K., Fujii T., Ueda S., Tachibana M., Suzuki N., Inoue M., Soma G., Nagasue N. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res. 23:2003;5015-5022
35. Ishigami S., Natsugoe S., Tokuda K., Nakajo A., Okumura H., Matsumoto M., Miyazono F., Hokita S., Aikou T. Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res. 23:2003;4079-4083
36. Gronski T.J. Jr, Martin R.L., Kobayashi D.K., Walsh B.C., Holman M.C., Huber M., Van Wart H.E., Shapiro S.D. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem. 272:1997;12189-12194
37. Dong Z., Kumar R., Yang X., Fidler I.J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell. 88:1997;801-810
38. Cornelius L.A., Nehring L.C., Harding E., Bolanowski M., Welgus H.G., Kobayashi D.K., Pierce R.A., Shapiro S.D. Matrix metalloproteinases generate angiostatin effects on neovascularization. J Immunol. 161:1998;6845-6852